Related Experiment Video
Updated: Oct 4, 2025

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
Published on: March 7, 2025
Transcriptional determinants of cancer immunotherapy response and resistance
Romi Gupta1, Amitkumar Mehta2, Narendra Wajapeyee1
1Department of Biochemistry and Molecular Genetics, University of Alabama at Birmingham, Birmingham, AL 35233, USA; O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL 35233, USA.
Abstract:
The host immune response is a potent defense mechanism against cancer development and progression. To survive, cancer cells must develop mechanisms to evade the immune response. Based on this knowledge, a series of new therapies collectively referred to as immunotherapies have been developed and translated to the clinic for treating cancer patients. Although some cancer subtypes have shown strong clinical responses, including curative outcomes in some patients, immunotherapies have not worked as desired for some subtypes and forms of cancers. We provide an overview of the transcriptional mechanisms that drive the response and resistance to immunotherapies. We also discuss possible interventions to enhance the outcomes of immunotherapies by targeting dysregulated transcriptional networks in cancer cells.
Insights
Cancer cells evade immune defenses, leading to the development of immunotherapies. This study explores transcriptional mechanisms of immunotherapy response and resistance, suggesting interventions to improve cancer treatment outcomes.
Area of Science:
- Immunology
- Cancer Biology
- Molecular Biology
Background:
- The host immune system is crucial for preventing cancer development and progression.
- Cancer cells evolve immune evasion strategies to survive.
- Immunotherapies have emerged as a significant cancer treatment modality.
Purpose of the Study:
- To provide an overview of transcriptional mechanisms underlying response and resistance to cancer immunotherapies.
- To discuss potential interventions targeting transcriptional networks to enhance immunotherapy efficacy.
Main Methods:
- Literature review and synthesis of existing research on cancer immunology and transcriptional regulation.
- Analysis of transcriptional mechanisms driving immunotherapy response and resistance.
- Exploration of therapeutic strategies based on targeting transcriptional networks.
Main Results:
- Cancer immune evasion is a critical factor in treatment failure.
- Transcriptional networks play a key role in mediating both response and resistance to immunotherapies.
- Dysregulated transcriptional networks in cancer cells present therapeutic targets.
Conclusions:
- Understanding transcriptional mechanisms is vital for improving cancer immunotherapy outcomes.
- Targeting specific transcriptional networks offers a promising strategy to overcome immunotherapy resistance.
- Further research into these mechanisms could lead to more effective cancer treatments.
More Related Videos
Related Concept Videos
Tumor Immunotherapy
Treatment Resistant Cancers
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

